1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Influenza Vaccination Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Egg Based
  • 1.2.3 Cell Culture
  • 1.2.4 Recombinant
• 1.3 Market by Application
  • 1.3.1 Global Influenza Vaccination Market Share by Application: 2020 VS 2026
  • 1.3.2 Hospitals
  • 1.3.3 Research Organizations
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Influenza Vaccination Market Perspective (2015-2026)
• 2.2 Global Influenza Vaccination Growth Trends by Regions
  • 2.2.1 Influenza Vaccination Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Influenza Vaccination Historic Market Share by Regions (2015-2020)
  • 2.2.3 Influenza Vaccination Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Influenza Vaccination Players by Market Size
  • 3.1.1 Global Top Influenza Vaccination Players by Revenue (2015-2020)
  • 3.1.2 Global Influenza Vaccination Revenue Market Share by Players (2015-2020)
• 3.2 Global Influenza Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Influenza Vaccination Revenue
• 3.4 Global Influenza Vaccination Market Concentration Ratio
  • 3.4.1 Global Influenza Vaccination Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Influenza Vaccination Revenue in 2019
• 3.5 Key Players Influenza Vaccination Area Served
• 3.6 Key Players Influenza Vaccination Product Solution and Service
• 3.7 Date of Enter into Influenza Vaccination Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Influenza Vaccination Breakdown Data by Type (2015-2026)

• 4.1 Global Influenza Vaccination Historic Market Size by Type (2015-2020)
• 4.2 Global Influenza Vaccination Forecasted Market Size by Type (2021-2026)

5 Influenza Vaccination Breakdown Data by Application (2015-2026)

• 5.1 Global Influenza Vaccination Historic Market Size by Application (2015-2020)
• 5.2 Global Influenza Vaccination Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Influenza Vaccination Market Size (2015-2026)
• 6.2 North America Influenza Vaccination Market Size by Type (2015-2020)
• 6.3 North America Influenza Vaccination Market Size by Application (2015-2020)
• 6.4 North America Influenza Vaccination Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Influenza Vaccination Market Size (2015-2026)
• 7.2 Europe Influenza Vaccination Market Size by Type (2015-2020)
• 7.3 Europe Influenza Vaccination Market Size by Application (2015-2020)
• 7.4 Europe Influenza Vaccination Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Influenza Vaccination Market Size (2015-2026)
• 8.2 China Influenza Vaccination Market Size by Type (2015-2020)
• 8.3 China Influenza Vaccination Market Size by Application (2015-2020)
• 8.4 China Influenza Vaccination Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Influenza Vaccination Market Size (2015-2026)
• 9.2 Japan Influenza Vaccination Market Size by Type (2015-2020)
• 9.3 Japan Influenza Vaccination Market Size by Application (2015-2020)
• 9.4 Japan Influenza Vaccination Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Influenza Vaccination Market Size (2015-2026)
• 10.2 Southeast Asia Influenza Vaccination Market Size by Type (2015-2020)
• 10.3 Southeast Asia Influenza Vaccination Market Size by Application (2015-2020)
• 10.4 Southeast Asia Influenza Vaccination Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Abbott (U.S.)
  • 11.1.1 Abbott (U.S.) Company Details
  • 11.1.2 Abbott (U.S.) Business Overview
  • 11.1.3 Abbott (U.S.) Influenza Vaccination Introduction
  • 11.1.4 Abbott (U.S.) Revenue in Influenza Vaccination Business (2015-2020))
  • 11.1.5 Abbott (U.S.) Recent Development
• 11.2 AstraZeneca (Europe)
  • 11.2.1 AstraZeneca (Europe) Company Details
  • 11.2.2 AstraZeneca (Europe) Business Overview
  • 11.2.3 AstraZeneca (Europe) Influenza Vaccination Introduction
  • 11.2.4 AstraZeneca (Europe) Revenue in Influenza Vaccination Business (2015-2020)
  • 11.2.5 AstraZeneca (Europe) Recent Development
• 11.3 BioCryst Pharmaceuticals, Inc. (U.S.)
  • 11.3.1 BioCryst Pharmaceuticals, Inc. (U.S.) Company Details
  • 11.3.2 BioCryst Pharmaceuticals, Inc. (U.S.) Business Overview
  • 11.3.3 BioCryst Pharmaceuticals, Inc. (U.S.) Influenza Vaccination Introduction
  • 11.3.4 BioCryst Pharmaceuticals, Inc. (U.S.) Revenue in Influenza Vaccination Business (2015-2020)
  • 11.3.5 BioCryst Pharmaceuticals, Inc. (U.S.) Recent Development
• 11.4 Novartis AG (Europe)
  • 11.4.1 Novartis AG (Europe) Company Details
  • 11.4.2 Novartis AG (Europe) Business Overview
  • 11.4.3 Novartis AG (Europe) Influenza Vaccination Introduction
  • 11.4.4 Novartis AG (Europe) Revenue in Influenza Vaccination Business (2015-2020)
  • 11.4.5 Novartis AG (Europe) Recent Development
• 11.5 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific)
  • 11.5.1 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Company Details
  • 11.5.2 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Business Overview
  • 11.5.3 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Influenza Vaccination Introduction
  • 11.5.4 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Revenue in Influenza Vaccination Business (2015-2020)
  • 11.5.5 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Recent Development
• 11.6 GlaxoSmithKline plc. (Europe)
  • 11.6.1 GlaxoSmithKline plc. (Europe) Company Details
  • 11.6.2 GlaxoSmithKline plc. (Europe) Business Overview
  • 11.6.3 GlaxoSmithKline plc. (Europe) Influenza Vaccination Introduction
  • 11.6.4 GlaxoSmithKline plc. (Europe) Revenue in Influenza Vaccination Business (2015-2020)
  • 11.6.5 GlaxoSmithKline plc. (Europe) Recent Development
• 11.7 Hualan Biological Engineering Inc (Asia Pacific)
  • 11.7.1 Hualan Biological Engineering Inc (Asia Pacific) Company Details
  • 11.7.2 Hualan Biological Engineering Inc (Asia Pacific) Business Overview
  • 11.7.3 Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Introduction
  • 11.7.4 Hualan Biological Engineering Inc (Asia Pacific) Revenue in Influenza Vaccination Business (2015-2020)
  • 11.7.5 Hualan Biological Engineering Inc (Asia Pacific) Recent Development
• 11.8 Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
  • 11.8.1 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Company Details
  • 11.8.2 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Business Overview
  • 11.8.3 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Introduction
  • 11.8.4 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Revenue in Influenza Vaccination Business (2015-2020)
  • 11.8.5 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Recent Development
• 11.9 F. Hoffmann-La Roche Ltd (Europe)
  • 11.9.1 F. Hoffmann-La Roche Ltd (Europe) Company Details
  • 11.9.2 F. Hoffmann-La Roche Ltd (Europe) Business Overview
  • 11.9.3 F. Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Introduction
  • 11.9.4 F. Hoffmann-La Roche Ltd (Europe) Revenue in Influenza Vaccination Business (2015-2020)
  • 11.9.5 F. Hoffmann-La Roche Ltd (Europe) Recent Development
• 11.10 Sanofi (Europe)
  • 11.10.1 Sanofi (Europe) Company Details
  • 11.10.2 Sanofi (Europe) Business Overview
  • 11.10.3 Sanofi (Europe) Influenza Vaccination Introduction
  • 11.10.4 Sanofi (Europe) Revenue in Influenza Vaccination Business (2015-2020)
  • 11.10.5 Sanofi (Europe) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Influenza Vaccination Scope and Market Size
Influenza Vaccination market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Vaccination market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Egg Based
Cell Culture
Recombinant

Market segment by Application, split into
Hospitals
Research Organizations

Based on regional and country-level analysis, the Influenza Vaccination market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Influenza Vaccination market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Abbott (U.S.)
AstraZeneca (Europe)
BioCryst Pharmaceuticals, Inc. (U.S.)
Novartis AG (Europe)
DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific)
GlaxoSmithKline plc. (Europe)
Hualan Biological Engineering Inc (Asia Pacific)
Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
F. Hoffmann-La Roche Ltd (Europe)
Sanofi (Europe)